The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) has posed a great threat to public health. Among 133 nonduplicated CRKP isolates collected between September 2016 and November 2017 in a tertiary hospital in China, 89 (89/133, 66.9%) and 31 (31/133, 23.3%) were positive for blaNDM-5 and blaKPC-2. Multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) revealed that ST290 represented the majority of NDM-5 producers (67/89, 75.3%) and PFGE cluster E accounted for 50 (50/67, 74.6%) ST290 isolates from the burn ward, suggesting that K. pneumoniae ST290 clone carrying blaNDM-5 resulted in an outbreak in this hospital. Whole genome sequencing of the plasmid carrying blaNDM-5 showed that the resistance gene blaNDM-5 was located in a ∼49 kb multireplicon plasmid with a peculiar insertion of ISKpn19 of the IncX3-type plasmid. To the best of our knowledge, this is the first report of outbreak of K. pneumoniae ST290 clone carrying blaNDM-5.
HidronA.I., EdwardsJ.R, PatelJ., HoranT.C, SievertD.M, PollockD.A, FridkinS.K, National Healthcare Safety NetworkT., and Participating National Healthcare Safety NetworkF.2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect. Control Hosp. Epidemiol. 29:996–1011.
NordmannP., CuzonG., and NaasT.2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228–236.
5.
QiY., WeiZ., JiS., DuX., ShenP., and YuY.2011. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J. Antimicrob. Chemother. 66:307–312.
6.
HornseyM., PheeL., and WarehamD.W.2011. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55:5952–5954.
7.
ChenD., GongL., WalshT.R, LanR., WangT., ZhangJ., MaiW., NiN., LuJ., XuJ., and LiJ.2016. Infection by and dissemination of NDM-5-producing Escherichia coli in China. J. Antimicrob. Chemother. 71:563–565.
8.
de ManT.J., PerryK.A, AvillanJ.J, RasheedJ.K, and LimbagoB.M.2015. Draft Genome Sequence of a New Delhi Metallo-beta-Lactamase-5 (NDM-5)-producing multidrug-resistant Escherichia coli isolate. Genome Announc., 3: pii: e00017-15.
9.
NakanoR., NakanoA., HikosakaK., KawakamiS., MatsunagaN., AsaharaM., IshigakiS., FurukawaT., SuzukiM., ShibayamaK., and OnoY.2014. First report of metallo-beta-lactamase NDM-5-producing Escherichia coli in Japan. Antimicrob. Agents Chemother. 58:7611–7612.
10.
ParkM., ParkS.D, LeeM.H, KimS.H, LimK., LeeG., WooH.J, KimH.W, YangJ.Y, EomY.B, MoonC., UhY. and KimJ.B.2016. The first report of NDM-5-producing uropathogenic Escherichia coli isolates in South Korea. Diagn. Microbiol. Infect. Dis. 85:198–199.
11.
SolimanA.M., KhalifaH.O, AhmedA.M, ShimamotoT., and ShimamotoT.2016. Emergence of an NDM-5-producing clinical Escherichia coli isolate in Egypt. Int. J. Infect. Dis. 48:46–48.
12.
WailanA.M., PatersonD.L, CafferyM., SowdenD., and SidjabatH.E.2015. Draft genome sequence of NDM-5-producing Escherichia coli sequence type 648 and genetic context of blaNDM-5 in Australia. Genome Announc., 3: pii: e00194-15.
13.
YousfiM., MairiA., BakourS., TouatiA., HassissenL., HadjadjL., and RolainJ.M.2015. First report of NDM-5-producing Escherichia coli ST1284 isolated from dog in Bejaia, Algeria. New Microbes New Infect. 8:17–18.
14.
ZhangL.P., XueW.C, and MengD.Y.2016. First report of New Delhi metallo-beta-lactamase 5 (NDM-5)-producing Escherichia coli from blood cultures of three leukemia patients. Int. J. Infect. Dis. 42:45–46.
15.
CLSI. 2018. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Document M100-S28. Clinical and Laboratory Standards Institute, Wayne, PA.
16.
PoirelL., WalshT.R, CuvillierV., and NordmannP.2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–123.
17.
QueenanA.M., and BushK.2007. Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev. 20:440–458, table of contents.
TamuraK., PetersonD., PetersonN., StecherG., NeiM., and KumarS.2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731–2739.
20.
NordmannP., PoirelL., and WalshT.R.2011. The emerging NDM carbapenemases. Trends Microbiol. 19:588–595.
21.
PoirelL., and NordmannP.2006. Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:1442–1448.
22.
BathoornE., RossenJ.W, LokateM., FriedrichA.W, and HammerumA.M.2015. Isolation of an NDM-5-producing ST16 Klebsiella pneumoniae from a Dutch patient without travel history abroad, August 2015. Euro. Surveill. 20:41.
23.
KhalifaH.O., SolimanA.M, AhmedA.M, ShimamotoT., and ShimamotoT.2016. NDM-4- and NDM-5-producing Klebsiella pneumoniae coinfection in a 6-month-old infant. Antimicrob. Agents Chemother. 60:4416–4417.
24.
LiuP.P., LiuY., WangL.H, WeiD.D, and WanL.G.2016. Draft Genome Sequence of an NDM-5-Producing Klebsiella pneumoniae sequence type 14 strain of serotype K2. Genome Announc., 4: pii: e01610-15.
25.
ShinJ., BaekJ.Y, ChungD.R, and KoK.S.2017. Instability of the IncFII-type plasmid carrying blaNDM-5 in a Klebsiella pneumoniae isolate. J. Microbiol. Biotechnol. 27:1711–1715.
26.
TakeuchiD., AkedaY., YoshidaH., HagiyaH., YamamotoN., NishiI., YoshiokaN., SugawaraY., SakamotoN., ShanmugakaniR.K, DeguchiM., TomonoK., and HamadaS.2018. Genomic reorganization by IS26 in a blaNDM-5-bearing FII plasmid of Klebsiella pneumoniae isolated from a patient in Japan. J. Med. Microbiol. 67:1221–1224.
27.
HammerumA.M., HansenF., OlesenB., StruveC., HolzknechtB.J, AndersenP.S, ThyeA.M, JakobsenL., RoderB.L, SteggerM., and HansenD.S.2015. Investigation of a possible outbreak of NDM-5-producing ST16 Klebsiella pneumoniae among patients in Denmark with no history of recent travel using whole-genome sequencing. J. Glob. Antimicrob. Resist. 3:219–221.
28.
HowardJ.C., CreightonJ., HeffernanH., and WernoA.2017. Evidence of transmission of an NDM-5-producing Klebsiella pneumoniae in a healthcare facility in New Zealand. J. Antimicrob. Chemother. 72:949–951.
29.
JinY., SongX., LiuY., WangY., ZhangB., FanH., and ShaoC.2017. Characteristics of carbapenemase-producing Klebsiella pneumoniae as a cause of neonatal infection in Shandong, China. Exp. Ther. Med. 13:1117–1126.
